Science Current Events | Science News |

Anti-HIV drug simulation offers 'realistic' tool to predict drug resistance and viral mutation

September 04, 2012
Computer model should help develop better anti-HIV drug combination therapies

Pooling data from thousands of tests of the antiviral activity of more than 20 commonly used anti-HIV drugs, AIDS experts at Johns Hopkins and Harvard universities have developed what they say is the first accurate computer simulation to explain drug effects. Already, the model clarifies how and why some treatment regimens fail in some patients who lack evidence of drug resistance. Researchers say their model is based on specific drugs, precise doses prescribed, and on "real-world variation" in how well patients follow prescribing instructions.

Johns Hopkins co-senior study investigator and infectious disease specialist Robert Siliciano, M.D., Ph.D., says the mathematical model can also be used to predict how well a patient is likely to do on a specific regimen, based on their prescription adherence. In addition, the model factors in each drug's ability to suppress viral replication and the likelihood that such suppression will spur development of drug-resistant, mutant HIV strains.

"With the help of our simulation, we can now tell with a fair degree of certainty what level of viral suppression is being achieved - how hard it is for the virus to grow and replicate - for a particular drug combination, at a specific dosage and drug concentration in the blood, even when a dose is missed," says Siliciano, a professor at the Johns Hopkins University School of Medicine and a Howard Hughes Medical Institute investigator. This information, he predicts, will remove "a lot of the current trial and error, or guesswork, involved in testing new drug combination therapies."

Siliciano says the study findings, to be reported in the journal Nature Medicine online Sept. 2, should help scientists streamline development and clinical trials of future combination therapies, by ruling out combinations unlikely to work.

One application of the model could be further development of drug combinations that can be contained in a single pill taken once a day. That could lower the chance of resistance, even if adherence is not perfect. Such future drug regimens, he says, will ideally strike a balance between optimizing viral suppression and minimizing risk of drug resistance.

Researchers next plan to expand their modeling beyond blood levels of virus to other parts of the body, such as the brain, where antiretroviral drug concentrations can be different from those measured in the blood. They also plan to expand their analysis to include multiple-drug-resistant strains of HIV.

Besides Siliciano, Johns Hopkins joint medical-doctoral student Alireza Rabi was a co-investigator in this study. Other study investigators included doctoral candidates Daniel Rosenbloom, M.S.; Alison Hill, M.S.; and co-senior study investigator Martin Nowak, Ph.D. - all at Harvard University.

Funding support for this study, which took two years to complete, was provided by the National Institutes of Health, with corresponding grant numbers R01-MH54907, R01-AI081600, R01-GM078986; the Bill and Melinda Gates Foundation; the Cancer Research Institute; the National Science Foundation; the Howard Hughes Medical Institute; Natural Sciences and Engineering Research Council of Canada; the John Templeton Foundation; and J. Epstein.

Currently, an estimated 8 million of the more than 34 million people in the world living with HIV are taking antiretroviral therapy to keep their disease in check. An estimated 1,178,000 in the United States are infected, including 23,000 in the state of Maryland.


For additional information, go to:

Johns Hopkins Medicine

Related Combination Therapies Current Events and Combination Therapies News Articles

Professor Janet Hemingway, outlines 15 years of malaria interventions in Africa
In an editorial in the weekly science journal Nature, LSTM's Director, Professor Janet Hemingway, looks at how the last 15 years of control measures have led to massive reductions in disease prevalence in Africa since 2000.

Breakthrough study demonstrates survival advantage with immune checkpoint inhibitor for advanced kidney cancer patients
For the first time, an immune checkpoint inhibitor has been proven to increase survival among patients with advanced renal cell carcinoma (RCC), a patient population for whom treatment options are currently limited.

Future of HIV cure research points to combination approach
The next five years of HIV research should shift gears from the classic single-therapy development model to moving directly from in vitro studies to combination therapy trials, authors argue in a new paper published online today.

Alzheimer's-disease-related proteases control axonal guidance by regulating growth cone dynamics
Alzheimer's-disease-related proteases, BACE1 and APH1B-y-secretase, control axonal guidance by regulating growth cone dynamics

An antibody that can attack HIV in new ways
Proteins called broadly neutralizing antibodies (bNAbs) are a promising key to the prevention of infection by HIV, the virus that causes AIDS. bNAbs have been found in blood samples from some HIV patients whose immune systems can naturally control the infection.

Clinical trial for first oral drug candidate specifically developed for sleeping sickness
The Drugs for Neglected Diseases initiative (DNDi) has announced today at the 9th European Congress on Tropical Medicine and International Health (ECTMIH) in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.

Researchers find new clue to halting leukemia relapse
A protein domain once considered of little importance may be key to helping patients who are fighting acute myeloid leukemia (AML) avoid a relapse.

Targeted therapy shows effectiveness against a subtype of the brain tumor medulloblastoma
A targeted therapy already used to treat advanced skin cancer is also effective against the most common subtype of the brain tumor medulloblastoma in adults and should be considered for treatment of newly diagnosed patients, according to research led by St. Jude Children's Research Hospital.

Patient cancer cells help to test treatments
A study, published today in Cell, demonstrates the power of organoids to capture, in three dimensions, the multiple mutations that occur in tumours.

TGen-UCSF study in Neuro-Oncology provides comprehensive look at brain cancer treatments
Led by the Translational Genomics Research Institute (TGen) and UC San Francisco (UCSF), a comprehensive genetic review of treatment strategies for glioblastoma brain tumors was published today in the Oxford University Press journal Neuro-Oncology.
More Combination Therapies Current Events and Combination Therapies News Articles

Antiepileptic Drugs: Combination Therapy and Interactions

Antiepileptic Drugs: Combination Therapy and Interactions
by Jerzy Majkowski (Editor), Blaise F. D. Bourgeois (Editor), Philip N. Patsalos (Editor), Richard H. Mattson (Editor)

This book reviews the use of antiepileptic drugs focusing on the interactions between these drugs and between antiepileptics and other drugs. These interactions can be beneficial or can cause harm. The aim of this book is to increase awareness of the possible impact of combination pharmacotherapies. Pharmacokinetic and pharmacodynamic interactions are discussed supported by clinical and experimental data. The book consists of five sections covering the general concepts and advantages of combination therapies, the principles of drug interactions, the mechanisms of interactions, drug interactions in specific populations or in patients with co-morbid health conditions, and concludes with a look at the future directions for this field of research. The book will be of interest to all who...

Combination Therapy in Hypertension

Combination Therapy in Hypertension
by Joel M. Neutel (Author)

For over 30 years, the stepped care approach has been used in the management and treatment of hypertension. This approach advocates the use of initial monotherapy to reach the desired blood pressure, and the subsequent use of additional drugs with complementary modes of action, until the target BP is achieved. However, current control rates for hypertension suggest that such an approach may be outdated and no longer effective in the management of hypertension. Clinical trials have shown that more than 50% of patients require a combination of drug therapies to achieve their target BP. Some proponents of combination therapy have argued that the risk of adverse side effects and non-compliance will be lower than that compared to monotherapy, which initially requires higher doses to be...

Hematology - Oncology Therapy

Hematology - Oncology Therapy
by Michael Boyiadzis (Author), James Frame (Author), David R. Kohler (Author), Tito Fojo (Author)

The Essential Therapy Guide to Cancer, Hematologic Disorders, and Supportive Care--Updated with the Latest Treatment Regimens More than 500 treatment regimens Hematology-Oncology Therapy, Second Edition is an up-to-date, comprehensive therapy guide that delivers more than 500 treatment regimens in a succinct, uniform manner. The unique tabular design allows you to instantly locate and implement the proper treatment regimen. Supported by the latest practice guidelines, peer-reviewed literature, and the opinion of experts, Hematology-Oncology Therapy integrates extensive information that is critical to both office- and hospital-based practice of hematology and oncology. Hematology-Oncology Therapy is divided into three sections: Oncology:
Provides detailed information about the...

Textbook of Facial Rejuvenation: The Art of Minimally Invasive Combination Therapy

Textbook of Facial Rejuvenation: The Art of Minimally Invasive Combination Therapy
by Nicholas J. Lowe (Editor), Alastair Carruthers (Editor), Jean Carruthers (Editor), Zoe Diana Draelos (Editor), Richard Glogau (Editor), Christopher Griffiths (Editor), Arnold W. Klein (Editor), Gary Lask (Editor)

In recent years the demand for rejuvenating treatments for the face has grown dramatically for both men and women. Alongside that demand, a wide variety of treatments have evolved, and a combination of different treatments can often result in much greater improvement than single-treatment approaches. With contributions from an impressive cast of international experts, Textbook of Facial Rejuvenation details current treatments, recommends approaches, and suggests how they may be tailored towards individual needs and combined for optimum results.

Studio Art Therapy: Cultivating the Artist Identity in the Art Therapist (Arts Therapies)

Studio Art Therapy: Cultivating the Artist Identity in the Art Therapist (Arts Therapies)
by Catherine Hyland Moon (Author)

Arguing that the profession of art therapy has its roots in the studio environment, Catherine Moon proposes that it is now time to reclaim these roots, and make art once again central to art therapy. She suggests that there has been a tendency for art therapy not merely to interact with and be enriched by other perspectives - psychological, social, anthropological and transpersonal - but to be subsumed by them. For this reason she makes a clear distinction between using art in one's practice of therapy, and working from an art-based model. This book presents a model of art therapy where the products and processes of art constitute the core of the model, rather than serving as the impetus for adaptations of other theories of counseling or therapy. It addresses how an arts-based approach...

Combination Therapy In Dyslipidemia

Combination Therapy In Dyslipidemia
by Maciej Banach (Editor)

Comprising contributions from leading lipidologists from around the world, this book presents the latest and most comprehensive knowledge on the different options for combination therapy of dyslipidemia and includes discussion of future therapies that are currently in late stages of clinical evaluation. Dyslipidemia is a leading cause of cardiovascular morbidity and mortality and most patients with this condition fail to achieve adequate control of their serum lipid levels with monotherapy. However, recent US and European guideline recommendations, based on randomized, controlled trials, fail to discuss combination therapy options for patients with dyslipidemia.Statins remain the mainstay of drug therapy for hyperlipidemia and chapters in this book specifically examine the role of add-on...

Condition-Specific Massage Therapy (LWW Massage Therapy and Bodywork Educational Series)

Condition-Specific Massage Therapy (LWW Massage Therapy and Bodywork Educational Series)
by Celia Bucci MA LMT (Author)

Condition-Specific Massage Therapy is a versatile book that outlines treatment goals for relieving musculoskeletal conditions in the context of a relaxation/wellness massage session. Students in a basic 500-700 hour program and practicing therapists will both benefit from the techniques outlined, as well as build upon critical thinking and basic massage skills. This book will prepare therapists and students both in the clinical and spa setting for dealing with common musculoskeletal conditions. Templated chapters for eleven of these common conditions apply foundational science to massage practice and move the student from understanding each condition to assessing and working with the client. Each chapter ends with a Professional Growth section, which encourages further exploration and...

Conn's Current Therapy 2015, 1e

Conn's Current Therapy 2015, 1e
by Edward T. Bope MD (Author), Rick D. Kellerman MD (Author)

Ideal for busy medical practitioners who need quick, reliable answers, Conn’s Current Therapy 2015 is an easy-to-use, in-depth guide that focuses solely on the most up-to-date treatment protocols for common complaints, acute disease and chronic illness. Drs. Edward T. Bope and Rick D. Kellerman present the expertise and knowledge of hundreds of skilled international leaders on evidence-based clinical management options. With key diagnostic points and treatment recommendation tables, you'll have quick access to the information you need to make accurate clinical decisions. Find answers quickly so you can dedicate more time to treatment with practical and accurate advice by renowned international experts on diagnosis and management, delivered via a templated, at-a-glance approach. Take it...

Clinician's Guide to Research Methods in Family Therapy: Foundations of Evidence-Based Practice

Clinician's Guide to Research Methods in Family Therapy: Foundations of Evidence-Based Practice
by Lee Williams PhD LMFT (Author), JoEllen Patterson Phd (Author), Todd M. Edwards PhD LMFT (Author)

A research methods text with a unique focus on evidence-based practice with couples and families, this book bridges the divide between research and clinical work. The text offers comprehensive, user-friendly coverage of measurement and design issues and basic qualitative and quantitative methods. Illustrating research concepts with clinically relevant examples and sample studies, it teaches clear steps for evaluating different types of studies and identifying common threats to validity. Of special value to therapists, it provides a systematic framework for using research to guide the selection and evaluation of interventions that meet the needs of particular clients.

 Pedagogical features:
*End-of-chapter "Applications" sections showing how to evaluate specific...

© 2015